Leucine zipper 4 autoantibody: a potential biomarker in germ-cell tumors

Takeaway

  • The leucine zipper 4 (LUZP4) antigen is a potential serological biomarker of germ-cell tumors and associated paraneoplastic neurological syndrome (PNS).

Why this matters

    The use of LUZP4 as a serological biomarker in PNS may be a useful tool to assist in detecting underlying cancer pathology in those with occult tumors with paraneoplastic neurological presentations.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.